Transient senescence is a deeply rooted evolutionary trait designed to temporarily halt progression through the cell-cycle and facilitate recruitment of immune cells to sites of tissue dyshomeostasis. Transient senescence is commonly observed during embryogenesis, healing, and early tumor development, where it is absolutely necessary for tissue survival. The senescent state is triggered in response to specific stress signals emanating from the local tissue microenvironment, and induces cellular reprogramming toward the senescence-associated secretory phenotype (SASP). The SASP prompts metabolic and epigenetic reprogramming and initiates immune action, eliciting an influx of immune cells capable of clearing debris, regenerating damaged tissue, and restoring tissue integrity. In this way, early SASP orchestrates immunosurveillance and supports efficient immune recognition and clearance.
In the instance of aging or in pathological conditions, the balance between immune activation and immune tolerance is disrupted, enabling perpetuity of cellular senescence. An acute response becomes a chronic state driven by immunosuppressive cues that allow for senescent cell persistence. SASP remodeling of immunomodulatory signals is context-dependent, varying based on the stressor, temporality, and cell type. Only specific cell subsets and senescence inducers appropriately propel T cell and NK cell cytotoxicity. Impaired immune function and defective inflammatory resolution can create ideal conditions that allow for senescent cells to evade immune recognition and eradication. Robust immunosurveillance is the key determinant of senescence ephemerality. Several factors can weaken immune defense, including propagation of senescence by immune cells themselves. These deficient immune cells prohibit prompt targeting of transient senescence and instead facilitate systemic progression of inflammation, immune tolerance, and senescent cell persistence.
Senescence is instigated by a number of stimuli, with antiviral sensing pathways serving as a key example. Senescence has been found to reinforce antiviral activity, exposing latent viral antigens for immune targeting. Antiviral pathways include the cyclic GMP-AMP synthase – stimulator of interferon genes (cGAS–STING) cytosolic nucleotide-sensing pathway; released mitochondrial DNA and RNA nucleic acids; cytoplasmic chromatin fragments leaked from the cell nucleus; activation of Long Interspersed Nuclear Element-1 (LINE-1) due to hypomethylation or loss of heterochromatin; as well as endogenous retroelements (DNA remnants of ancient viral infections passed down through generations), can all interact with type I interferon (IFN-I) to kick off an inflammatory cascade. The result is amplification of the SASP and consequent immune stimulation.
In the case of acute adaptive senescence, such as occurs during wound healing or tumor detection, SASP factors incite release of damage-associated molecular patterns (DAMPs). DAMPs interact with the innate immune receptor Toll-like receptor 2 (TLR2) on the senescent cell itself as well as neighboring cells to expedite immune cell recruitment. Macrophages, T cells, and NK cells flood the scene to surveil the area. Moreover, DAMPs and certain intrinsic signaling cascades activate the NLRP3 inflammasome within the microenvironment which amplifies immune cell cytotoxicity and phagocytic capacity. Senescence also instigates the expression of stress ligands which bolster immune cell antigen presentation and recognition, thereby ensuring efficient clearance of damaged cells.
During embryonic development, transient structures must be replaced by permanent ones. Senescence serves the vital role of removing temporary elements and preserving a healthy population of progenitor cells for new growth. Senescent cells attract macrophages that can engage in phagocytosis and assist in tissue patterning. Senescence is also critical for placental homeostasis and maintenance of immunotolerance, protecting the developing fetus from potential immune-mediated attack. Coordination of immune response and inflammatory activity for the sake of tissue regeneration is also a requisite of wound healing. Senescent cells are designed to cultivate an inflammatory microenvironment localized to the zone of tissue damage. The SASP releases remodeling factors that shape tissue architecture, participate in cellular reprogramming, and trigger dedifferentiation and lineage conversion in neighboring cells for the sake of tissue restoration. Once remodeling is complete, specific interleukins, such as IL-15, enlist the help of NK-cells which eliminate senescent cells, marking inflammatory resolution. Senescence is thus a pivotal component of tissue plasticity.
However, with age or pathology, continuous, coinciding stimuli reinforce IFN-I signaling that eventually diminishes generation of SASP factors, impairs immune recruitment, and disturbs debris removal, thus preventing inflammation resolution. Epigenetic programs are disrupted and adequate gene silencing is lost with age, leading to a perpetual reactivation of antiviral pathways. These reinforce IFN-1 response and the propagation of senescence. Aging and disease are also correlated with immunometabolic stress which incites metabolic alterations, including a deviation toward glycolysis and T helper 1 (Th1) or T helper 17 (Th17) polarization. Both Th1 and Th17 cells secrete IFN-y and Tumor Necrosis Factor-alpha (TNF-α), propelling systemic paracrine senescence.
Over time, temporary microenvironmental reprogramming and reshaping becomes chronic, leading to excessive immune cell invasion, inflammation, tissue injury, and fibrosis. Mitigating stress and chronic pathogen invasion necessitates repeated rounds of immune cell clonal expansion, as well as an immense repertoire of antibodies. Immune aging is molded with each subsequent exposure and slowly collects senescence markers. Senescent cells are equally victim of their own success, with the SASP compromising mitochondrial performance, cytotoxic potency, and genomic integrity. Old cells that have accumulated defects struggle to proliferate, and when they do their duplicates display degenerative function. Immune cells acquire senescence signatures with age and disease that, as previously stated, drastically reduces their function and immunosurveillance qualities. A weakened cytotoxic response allows for unopposed remodeling SASP factor secretion, creating a vicious cycle of incremental senescent cell accrual, SASP factor release, and dysregulated immune activity.
How control of a transient state is lost initially involves the expression of inhibitory ligands at the surface of senescent cells. Highly inflammatory senescent cells co-opt inhibitory checkpoint pathways, enabling them to survive in perpetuity. Secondly, augmented SASP signaling drives immunosuppression by engaging the p38 MAPK pathway. Senescent cells subsequently upregulate surface expression of the non-classical MHC molecule HLA-E, resulting in a repression of NK cell and CD8+ T cell cytotoxicity. Elevated expression of the Fas ligand by senescent cells additionally prompts NK cell and T cell apoptosis. Moreover, aging produces a rise in senescent cell glycolipid signaling that prevents NK cell degranulation.
Tumor cells behave in a similar fashion to enduring senescent cells, exploiting surface-ligand programs to avoid immune expulsion. To add insult to injury, myeloid-derived suppressor cells (MDSCs) aggregate in concert with cellular senescence. MDSCs counteract immunostimulation by the SASP to support tumor proliferation. In addition, senescent cells regulate intrinsic chromatin remodeling that impairs provocation of innate sensing pathways and acts as a camouflage to the immune system. Senescent cell modulation of their exterior microenvironment also serves to handicap immune cell cytotoxicity. Senescent cells cultivate inflammatory niches that hinder immune cell surveillance. Oncogenic treatments exacerbate these adaptive processes to further shield against immunosurveillance. Therapy-induced senescent cancer cells activate both complement protein C3 and complement regulatory proteins that collectively promote immunosuppression. Moreover, treatments can interact with the JAK2-STAT3 pathway to trigger a shift in the SASP toward one that is more immunosuppressive.
Extensive research has continued to elucidate the complex and functionally distinct iterations of senescence that span tissues and time. Senescence is a fundamentally conserved process implicated in tissue remodeling, regeneration and homeostasis, as well inflammation resolution. When transient senescence evades immunosurveillance, it progresses into a chronic state that rewires immunometabolism and immunosurveillance. Persistent SASP signaling feeds back to drive cell senescence and immunosuppression. Chronic senescence cultivates the ideal environment for metabolic aberrations, tissue fibrosis, and tumor progression. Novel therapeutic approaches that precisely target senescent cells, such as immunotherapies, pulsed administration of senolytics, and senescence-directed vaccines, restore immunosurveillance and promote attenuation of senescent cell burden. More studies are needed prior to maturation of new treatment strategies, but early interventions demonstrate promise in the mitigation of systemic senescence.
Zubova A, Pietrocola F, Morsli S. Immunological consequences of senescence in physiology and pathology. J Transl Med. 2026;24(1):747. Published 2026 Jun 6. doi:10.1186/s12967-026-08335-3